AIMP2-DX2 and its uses
US7459529B2 · kind B2 · utility
90Cited by
0References
3Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 1, 2005 |
| Grant date | Dec 2, 2008 |
| Priority date | — |
| Expiry date | Nov 1, 2025 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/00
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to a variant of AIMP2 lacking exon 2, named as AIMP2-DX2, which is specifically expressed in cancer cells. The AIMP2-DX2 protein and gene can be successfully used in the development of diagnosis and treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.